Status:
COMPLETED
Epilepsy Motion Sensing
Lead Sponsor:
MedtronicNeuro
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate patient motion during seizures.
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosed with epilepsy and expected to have at least one motor seizure in the EMU
- Determined by the Investigator to be an acceptable candidate for epilepsy evaluation with intracranial or scalp electrode monitoring
- Willing and able to wear 3 ActiGraph GT3X+ devices for the duration of their participation in the study and comply with the study protocol
- Have one of the following seizure types: (a) partial seizures with secondary generalization, which results in visible clonic or tonic-clonic motor behavior; (b) primarily generalized seizures (in patients with either primary \[idiopathic\] or secondary \[symptomatic\] generalized epilepsy), which may involve the following depending on the motor manifestation observed: myoclonic seizures, clonic seizures, tonic-clonic seizures, or atonic seizures.
- Be able to consent to participate by signing the Informed Consent document after a full explanation of the nature and purpose of this study
- Male or non-pregnant female
- English speaking
Exclusion
- Currently enrolled in another investigational device, drug, or surgery study. Concurrent physiologic study participation is acceptable
- Have an implanted device that may interfere with GT3X+ recordings, ECoG/EEG recordings, ECG recordings, or video recordings
- Have a movement disorder that may affect GT3X+ recordings
Key Trial Info
Start Date :
May 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01850498
Start Date
May 1 2012
End Date
April 1 2013
Last Update
May 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905